Parameter
| Biomarker | MicroRNA (MiR-31) | Full name | MicroRNA-31 | Molecular Type | Nucleic acid（DNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis |
| Disease | Endometrial Cancer | Disease Subtypes | / | ||
| Organ | Endometrium | Test Sample / Technology Platform | Organization, Serum (qRT-PCR) | ||
| Pathobiological Mechanisms | It affects the proliferation, invasion and chemosensitivity of tumor cells by regulating downstream target genes (such as SATB2). | ||||
| Clinical Availability Status | Research stage: Demonstrates potential as a prognostic marker and for predicting chemotherapy response. | ||||
| Notes and Dynamics | High expression is associated with poor prognosis and may serve as a potential biomarker for liquid biopsy. | ||||